等待開盤 02-07 09:30:00 美东时间
+1.920
+2.20%
Rosenblatt analyst Kevin Cassidy maintains Synaptics (NASDAQ:SYNA) with a Buy and raises the price target from $95 to $125.
02-06 21:09
华盛资讯2月6日讯,Synaptics Incorporated公布2025财年Q4业绩,公司Q4营收3.03亿美元,同比增长13.2%,归母净利润亏损0.15亿美元,由盈转亏。
02-06 17:49
华盛资讯2月6日讯,Synaptics Incorporated公布2025财年Q4业绩,公司Q4营收3.03亿美元,同比增长13.2%,归母净利润亏损0.15亿美元,由盈转亏。
02-06 13:34
Synaptics (NASDAQ:SYNA) is looking for Q3 GAAP EPS of $(0.71)-$(0.21) vs $(0.57) analyst estimate..
02-06 05:18
Synaptics (NASDAQ:SYNA) is looking for Q3 Adj EPS of $0.85-$1.15 vs $0.98 analyst estimate. sees sales of $280.000 million-$300.000 million vs $285.723 million analyst estimate.
02-06 05:18
The earnings results for Synaptics (NASDAQ:SYNA) for Q2 were made public on Thu...
02-06 05:18
As Intel's (INTC) weaker-than-expected outlook and supply constraints continued to pull down the shares of the company on Friday, we took a look at chip-related stocks and how they are rated on the Se...
01-23 23:03
今日重点评级关注:HC Wainwright & Co.:上调Tempest Therapeutics评级至"买入",目标价11美元;Guggenheim:维持Sportradar Gr"买入"评级,目标价从34美元升至35美元
01-23 19:46
Synaptics Officer and Director Rahul G. Patel Reports Disposal of Common Shares Rahul G. Patel, Director and Officer of Synaptics Incorporated, reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Publ
01-22 00:55
今日重点评级关注:Benchmark:维持TNL Mediagene"投机性买入"评级,目标价从3.5美元升至14美元;康托·菲茨杰拉德:维持Eupraxia Pharmaceuticals"超配"评级,目标价从11美元升至19美元
01-16 10:04